Suntrust Banks’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Suntrust Banks’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$502K	Buy	9,612 +1,002	+12%	+$48K	﹤0.01%	961
2019 Q2	$450K	Buy	8,610 +1,191	+16%	+$58.9K	﹤0.01%	997
2019 Q1	$388K	Buy	+7,419	New	+$369K	﹤0.01%	1008
2018 Q2	–	Sell	-8,235	Closed	-$415K	–	1333
2018 Q1	$415K	Buy	+8,235	New	+$423K	﹤0.01%	952

Other funds holding IHE

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

RCYC

Richard C. Young & Co Newport, Rhode Island $1.21B AUM 38.41% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Suntrust Banks's IHE Position: Q3 2019 in Review

Suntrust Banks increased its iShares US Pharmaceuticals ETF (IHE) stake by 12% in Q3 2019, buying an estimated $48K and bringing the position to 9,612 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Suntrust Banks first reported a position in IHE in Q1 2018 and has held it in 4 quarters since. 82 funds tracked by Wall St. Rank hold IHE as of Q3 2019.

Suntrust Banks held 9,612 shares of iShares US Pharmaceuticals ETF worth $502K as of Q3 2019.
Suntrust Banks bought 1,002 iShares US Pharmaceuticals ETF shares in Q3 2019, an estimated $48K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #961 holding.
Suntrust Banks first reported a position in iShares US Pharmaceuticals ETF in Q1 2018 and has held it in 4 quarters since.
82 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.